Fig. 7.

¹⁸F-florbetaben PET predicts outcome in mild cognitive impairment (MCI). Composite neocortical standardized uptake value ratios (SUVRs) in individuals with MCI who, at the 2-year (left) or 4-year (right) clinical follow-up progressed to dementia (dark-gray circles Alzheimer’s disease, white circles non-Alzheimer’s dementia) in comparison to those who remained non-demented (light-gray circles). High predictive power of ¹⁸F-florbetaben PET was calculated. Reproduced from ref. [33], with permission from BMJ Publishing Group Ltd